Association of erectile dysfunction with diabetic foot and its outcomes in type 2 diabetic men
暂无分享,去创建一个
C. Gazzaruso | L. Luzi | I. Terruzzi | A. Pujia | T. Montalcini | P. Gallotti | A. Coppola
[1] C. Gazzaruso,et al. Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study , 2020, Endocrine.
[2] D. Armstrong,et al. Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers , 2018, Diabetes Care.
[3] Sicco A Bus,et al. Diabetic Foot Ulcers and Their Recurrence. , 2017, The New England journal of medicine.
[4] Dalong Zhu,et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis† , 2017, Annals of medicine.
[5] H. Zhang,et al. Metabolic syndrome and risk for ED: a meta-analysis , 2014, International Journal of Impotence Research.
[6] C. Gazzaruso,et al. Transcutaneous Oxygen Tension as a Potential Predictor of Cardiovascular Events in Type 2 Diabetes , 2013, Diabetes Care.
[7] C. Gazzaruso,et al. Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients , 2012, Internal and Emergency Medicine.
[8] C. Gazzaruso,et al. Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus , 2012, Endocrine.
[9] C. Gazzaruso,et al. Erectile dysfunction and coronary artery disease in patients with diabetes. , 2011, Current diabetes reviews.
[10] A. Kong,et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. , 2008, Journal of the American College of Cardiology.
[11] C. Gazzaruso,et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. , 2008, Journal of the American College of Cardiology.
[12] C. Gazzaruso,et al. Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients , 2006, International Journal of Impotence Research.
[13] P. Fratino,et al. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. , 2006, The American journal of cardiology.
[14] F. Montorsi,et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. , 2005, The American journal of cardiology.
[15] P. Fratino,et al. Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism , 2002 .
[16] D. Cucinotta,et al. Incidence of erectile dysfunction in Italian men with diabetes. , 2001, The Journal of urology.
[17] J. Cappelleri,et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction , 1999, International Journal of Impotence Research.
[18] V. Froelicher,et al. Screening for asymptomatic coronary artery disease. , 1983, Journal of the American College of Cardiology.
[19] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[20] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[21] Steven W. Hwang,et al. Comorbidities associated with diabetic foot complications among Asian Americans in southern California. , 2003, Journal of the American Podiatric Medical Association.